|
⚲
|
| Keyboard |
| Minkow Emily
✚
|
|
|---|---|
| CIK # | 0001778491 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001778491] | |
| 4 | [0001778491] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Minkow Emily | |
| Prevail Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 149,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 54,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 108,854 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 104,895 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Common Stock
|
2021-01-22 | Tender | 13,000 | ||
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2020-02-19 | Grant | 54,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2019-12-24 | Option exercise | 13,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Common Stock
|
2019-12-24 | Option exercise | 13,000 | $0.18 | 2,340 |